Neutral
Wall Street Zen Downgrades CytomX Therapeutics (NASDAQ:CTMX) to Strong Sell
Wall Street Zen has downgraded CytomX Therapeutics (NASDAQ:CTMX) from "sell" to "strong sell" following the company's Q1 earnings miss and significant...